Every Form 4 that Innovative Eyewear, Inc. (LUCY) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow LUCY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LUCY filings page.
Innovative Eyewear Inc (LUCY) reported that Chief Financial Officer Gayle Oswald received two grants of 16,233 shares of common stock on April 2, 2026 and August 19, 2026 at $0.00 per share. On the same respective dates, she sold 7,574 shares at a $1.0725 average price and 7,959 shares at a $0.6745 average price in open market or private transactions. The filing’s Rule 10b5-1 checkbox is not marked as being pursuant to a trading plan, and it does not state her total holdings after these transactions.
Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief AI & Growth Officer Konrad Dabrowski. He received grants of 20,900 shares of common stock on April 2, 2026 and August 19, 2026, each at no cost, and sold 6,692 shares on April 2 at $1.0581 per share and 6,935 shares on August 19 at a weighted-average price of $0.6911 per share in open-market or private transactions. Post-transaction holdings were not provided.
Innovative Eyewear Inc (LUCY) reported insider equity activity by Chief Operating Officer Joaquin Abondano. On April 2 and August 19, 2026, he received two grants of 14,800 Common Shares each at $0.00 per share as awards. On the same dates, he sold 4,779 shares at $1.0501 per share and 5,020 shares at an average of $0.6765 per share in open-market or private transactions. The August 19 price is disclosed as a weighted average, with detailed trade breakdowns available on request. The filing states these transactions were not conducted under a Rule 10b5-1 trading plan.
Innovative Eyewear Inc (LUCY) reported that Chief Executive Officer and director Harrison R. Gross had both awards and sales of Common Stock. On April 2, 2026 and August 19, 2026, he received 24,600 shares on each date as a grant or award at $0.00 per share. On those same dates he sold shares in open market or private transactions, including 13,764 shares at an average price of $1.0658, 8,252 shares at an average price of $0.6916, and 5,722 shares at an average price of $0.705, with each price disclosed as a weighted average over multiple trades.
Innovative Eyewear Inc (LUCY) reported that Chief Technology Officer David Eric Cohen had a mix of stock grants and sales. On April 2 and August 19, 2026, he received 18,200 shares of common stock each time as grant/award acquisitions at $0.00 per share. Across April 2, April 9, July 6, and August 19, 2026, he sold a total of 15,769 shares of common stock in open-market or private transactions at per-share prices ranging from $1.0436–$1.17 and a weighted average price of $0.6802 for the August 19 sale.
Innovative Eyewear Inc. insider activity: Chief Executive Officer and director Harrison R. Gross reported buying 1,500 shares of Innovative Eyewear common stock on January 21, 2026 at a price of $1.32 per share. Following this purchase, he directly beneficially owns 13,733 common shares.
The filing notes that this transaction created a short-swing profit under Section 16(b) of the Securities Exchange Act of 1934. Gross agreed to voluntarily disgorge $1,036.20, described as the full amount of that profit, to Innovative Eyewear, and this amount was paid in full on January 21, 2026.
Innovative Eyewear Inc.'s Chief Financial Officer, Oswald Gayle, reported small open-market purchases of company stock and a related repayment of trading profit. On January 13, 2026, he bought 700 shares of common stock at $1.66 per share and another 300 shares at $1.69 per share, increasing his directly held stake to 2,865 shares.
The filing notes that these transactions resulted in a short-swing profit under Section 16(b) of the Securities Exchange Act of 1934. Gayle agreed to voluntarily disgorge $489.00, the full amount of that profit, back to Innovative Eyewear, and this amount was paid in full on January 15, 2026.
Innovative Eyewear Inc. Chief Executive Officer and director Harrison R. Gross reported buying 1,500 shares of the company’s common stock on January 8, 2026 at a price of $1.60 per share. After this transaction, he beneficially owned 12,233 common shares in total, held directly. The filing notes that this trade created a short-swing profit under Section 16(b) of the Securities Exchange Act, and Gross voluntarily paid $629.45, the full amount of that profit, back to the company on January 11, 2026.
Innovative Eyewear Inc. reported an insider share purchase by its Chief AI & Growth Officer, Konrad Dabrowski. On 01/08/2026, he bought 1,300 shares of the company’s common stock at a price of $1.58 per share, increasing his direct beneficial ownership to 12,804 shares.
The accompanying note states that this transaction resulted in a short-swing profit under Section 16(b) of the Securities Exchange Act of 1934. Dabrowski agreed to voluntarily disgorge $551.35, described as the full amount of that profit, to the issuer, and this amount was paid in full on January 12, 2026.
Innovative Eyewear Inc. 10% owner Vladimir Galkin reported recent trades in the company’s common stock. On January 2, 2026, he reported purchasing 4,000 shares of common stock at a volume‑weighted average price of $1.02 per share, bringing reported beneficial ownership to 643,505 shares.
On January 7, 2026, he reported an additional transaction of 643,505 shares at a volume‑weighted average price of $1.79 per share, after which the table shows 0 shares beneficially owned. The filing notes that these shares are held jointly by Vladimir and Angelica Galkin as husband and wife, and that prices are volume‑weighted averages that include commissions.
Innovative Eyewear Inc. director and 10% owner Vladimir Galkin reported multiple transactions in the company’s common stock. On 12/29/2025, he reported a transaction in 46,107 shares at a price of $1.10 per share, leaving 749,900 shares beneficially owned. On 12/30/2025, he reported 11,303 shares at $1.08 per share, with 738,597 shares beneficially owned afterward. On 12/31/2025, he reported 89,830 shares at $0.99 per share, leaving 648,767 shares beneficially owned. On 01/02/2026, he reported 1,262 shares at $0.97 per share, for a resulting beneficial ownership of 647,505 shares. The filing notes that the reported per share prices include commissions and that the shares are held jointly by Vladimir and Angelica Galkin.
Innovative Eyewear Inc director Vladimir Galkin reported two transactions in the company’s common stock. On 12/10/2025, a transaction labeled code 'P' involved 50,300 shares at $1.49 per share, leaving 947,193 shares beneficially owned directly afterward. On 12/11/2025, another code 'P' transaction covered 8,423 shares at $1.58 per share, with 938,770 shares beneficially owned directly afterward. The filing notes these common shares are held jointly by Vladimir and Angelica Galkin, husband and wife.
Innovative Eyewear Inc reported an insider stock purchase by director Vladimir Galkin. On 12/04/2025, he bought 2,507 shares of common stock at $1.5 per share in an open-market transaction classified as a purchase.
After this trade, Galkin beneficially owns 997,493 shares of Innovative Eyewear common stock. The filing explains that these shares are held jointly by Vladimir Galkin and his wife, Angelica Galkin, reflecting shared ownership within the household.